The Valley Desk

Clinical trial reportInvestigational new drugsPublished

A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Investigational new drugs
Published
Subject terms
Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasm Recurrence, Local; Aged; Female; Male; Tumor Microenvironment; Antibodies, Monoclonal, Humanized; Macrophage; Immunotherapy; Renal cell carcinoma
PubMed ID
38372949
Added to directory
Source checked

Report a correction or request removal